DNX-514

N/A

Report date: 2023/01/07 16:59:39

Base Information

Drug NameDNX-514
Drug Alias NameDNX-514
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsPlaque psoriasisCrohn DiseaseColitis, Ulcerative +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDnx Biopharmaceuticals IncXL-protein GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXL-protein GmbH
Active IndicationsN/A
Inactive IndicationsPlaque psoriasisCrohn DiseaseColitis, Ulcerative +[7] 

Other Information

ATC CodeN/A
Related LinksN/A